Triptan safety — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Do not supply and advise medical review of migraine and BP
Triptans are contraindicated or unsuitable in uncontrolled hypertension because of vasoconstrictive effects and cardiovascular risk. The patient needs review of both migraine treatment and BP control. Sumatriptan is used for acute migraine, not daily prevention. Combining with sympathomimetics would add risk.
Reference: BNF